Grace Therapeutics Inc
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
GRCE$1.85+3.9%Stored close · as of Nov 6, 2026
Contents
Item 1. Financial Statements
Unaudited Condensed Consolidated Financial Statements
| Condensed Consolidated Balance Sheets | 6 |
|---|---|
| Condensed Consolidated Statements of Loss and Comprehensive Loss | 7 |
| Condensed Consolidated Statements of Shareholders’ Equity | 8 |
| Condensed Consolidated Statements of Cash Flows | 9 |
| Notes to the Unaudited Condensed Consolidated Financial Statements | 10 |
Condensed Consolidated
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.